pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1470 |
Genomic Coordinates | chr19: 15449548 - 15449608 |
Synonyms | MIRN1470, hsa-mir-1470, MIR1470 |
Description | Homo sapiens miR-1470 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1470 | |||||||||||||||||||||||||||
Sequence | 1| GCCCUCCGCCCGUGCACCCCG |21 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SKIL | ||||||||||||||||||||
Synonyms | SNO, SnoA, SnoI, SnoN | ||||||||||||||||||||
Description | SKI like proto-oncogene | ||||||||||||||||||||
Transcript | NM_001145097 | ||||||||||||||||||||
Other Transcripts | NM_001145098 , NM_005414 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SKIL | |||||||||||||||||||||
3'UTR of SKIL (miRNA target sites are highlighted) |
>SKIL|NM_001145097|3'UTR 1 AAACTGTTAAAGAGATTCATCTGTGTATTACTGACAAGGTTTTTTTTGTTTGTTGCTTGCTTTGGTAATTGAATTCTGAA 81 GAATTTATCTGCATGACGATAACTAGGCATTCTATCCATTTGTAGATCAGAGAAAGTGAAGAGATTATATATTAGTACTT 161 AAATTTTTACATTTTCCAAATGAATGAAAATGTATGTTTCTTTGTACTTTTTTAAAAAAATCAGCTTAGTAACAATACTA 241 TATGGTTTCAACTAGTAGGTAATCTGCTTATATTTCTAATGCAAACTTAACAATTGTGTACTTTTTAAAAGCTGCAATAT 321 GTGTTGGAAAATAGCTGTGGTCAATTTTGTTATCCATATTTCAGACTCAATTTTAGATACAATGGTGGCTTTATATTTTA 401 AGTATATAGAGCTACTCAAGGAGTTGAATCTCCCCTTTTCTCATTAACACAATTTTTCTAAGTTGATATGGTGTACTCAT 481 TAACATACACCAAATTTACTTTTACTTTGTTCAGATTGTGGAATGAATTTCCACCAGTTCTCTTCTTTTTAATGTGTACC 561 CTAGGAGGAATTTTACTGAGGTTATAGCATACCCCATGAGCACAGTGGGGAAGAAGAATGTGTTGTTATGTGCTGCTGCT 641 AAACAGAAGCAGCAGTTGTAATTTGTTTTTCAGTTTAAATGTGGTTATAGTTAGATTTTTTTTTAAGCAGCAACTTTTCA 721 AAAATAAAATGTGATAATTTCTGAACTTTTGTTTGTGTTGTTAATAGTGGTGTGAAAATATTAACGTTCTTGAGAAAAAC 801 TGATACCACTGTTGTGTATCAGTTTCTATACAATCCATAATCCTCCTGTACAGTTTTTACATGTAGTTATGAGTCTTACT 881 AAAATTTATATAATGGACTTGTTTTCCTTTAAGTTGTAAAATGTTAAACACCTTGAAGGTTATTTTGGACTTCTGTATGT 961 TTAAATGTTGTCTTACCAAAATTTGCACGAATGGACCATTTTCATTTACTACTTAATATCAAAATCAGGAATTTACAGTC 1041 AACTGATAGTACATGATAGGTGCATATAGGACAGTTTAGTTACCTGCTACTAAAAGATTTTTAGATAAGTTTTAGAAGAT 1121 AAAGGAATTCCATAGTTTCAGGAGGGACAACATCTTCTGCACTTTTTTTTTGCACAGAAAAGTCTGTCATTCTCTAATGG 1201 CAAATTTCATATTTGTTAATTCTTGGCTCAAAATATATTAGGTAAAATTCTTAGATCTGTTTTTAAAGGGAGTTTCCTGA 1281 AACTATCATTAATTGACATTATTACCCCATGGATTTTATGGGATAATAAATGTTTTTCATGTTCTCTTATAAGATACTAT 1361 GTATGAAATTACTTCAGAGAGCTATATTTATTTTAAAATAAATTAGCTAGGGTTAAGGTTATATTCTATTTCCAGCATAG 1441 AAGGTAGATAATCTAATGGTGTAGAAAGAATCACTAGGTTGTCATTTAACCAGTTATTTTCATATTTTGCTTAATAGTAC 1521 ATATCCAAAAAGAATTTTGTACTTCCCCAAATGTAATTTATTTACTAAATTGAGTATAACCTAAATGTGTGTTTTCTATT 1601 TTCCATTTAAATTTTGCTATATTAAGACTAATTTAATTCGTTGAGTCTTGGAATCTTCTCAAGGAGGAACAAATATTAAA 1681 ATGACATGTAGAAACAAATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTCGCTGTCTCCCAGGCTGGA 1761 GTTCAGTGGTGCAATCTCGGCTCACTGCAAGCTCTGCCTCCTGGGTTCAAGCCATTCTCCTGCCTCAGCCTCCCGAGTAG 1841 CTGGGACTACAGGCACCCACCACCACTCCCGGCTAATTTTTAGAAACAAATATTTAAAATGACATATTCTCCCAATACAA 1921 TCTATTTAGATCTGGAGAAGGAAAAATCAGATATTTATGATATAGTTTTATTTTAATTTTGAATTATTTGTGTCACAGCT 2001 CAGCTTTTTGGAAGACAAACTCAAACACCTATAATTTCATTTATATTTCTAATTCACTTGGAACCTTTCTGCTTTATGTT 2081 ACCTAGAAAATGATAATTTGTTTAACCCAAAACTTCTAAAATAAATTGCTTAATCCTTGAAATATGTTATTGGAAAATTT 2161 TAAGCAGTGCTTAAACACCATTAAATTATTATGAACTTGTAATTCAGAATTGAGTAAAGAAATATTTTTTCTAGTCCTTC 2241 ATATATTGAAAACTTGCCACATGACATTGTATCGTCTTCATTTTCCAGAAGATGCGTTGGTGTGCCATAGGTTTCTAACT 2321 TCCTTGAAAATAGTTTTTTAAGTCAATTGTAAATATACGTATTATTGTTAAAAGTAACTTTAAACTGCAACACATAGCTT 2401 CAAAACAATATAGAGATTTTGTAATACCTTATAAGTGGAGTTGGCTAAAATACCTTATCCATATAAAACTTATTCTATTC 2481 TTTGCATGCTTATTTTGTGTGTTGGTTGCTAGCTTAAAGTTTGATTTGTTGTTACTCTTTGTGTGCCAAATTCACTAGGC 2561 AAGCGGATTTTTCCTCAGACTTCAAAAAATAATTCTTTTAAGAAAAAATGTAAAAATGTTTATTCTAAAAAGCTGCATTA 2641 AAGGGACAACCTATAAAAAGTTTTGCTAGCTCATCTTTAGAAGGAAGAAAGAATATTAGCTTGGGTGATGTTTAATTTGG 2721 GTGGCGATAGTTTCTGTAGGCTAAACTTTATGAGAAAAGTGTACCTACTCTATAAAGGTAATAAATGTAAAACCTCTTGC 2801 TGTTATTGAGGAAGCTCTTCAACTACCCTAAATTTCACAAATGTAACTTATAACACTATGAAAAGATTTGACCAACAATT 2881 TACGTTTGCTGTGTGCTTTAGTTTTTGTTTAAGCATATTCTTTTGCTTGAATTTCTGTGTTCATGAGAGTTAGGGTGTTT 2961 TATGCTTCTTGAACTAATTTTATAACATATTTAATATATTACCAGTTAAGATATAAAATCATTTGTACATAGCGAATTGT 3041 AAAGCAGCTATTAAAGTAGGTGAAATAAAGTATATATTTGCCGGTTATCCATATCTTTTAGAAGTCCTGACAGAACAACC 3121 AGTTTATTTGCACATAGGTAGCTTCTGTTTGAAGGAAGGTAAAGTTATAAGGAAACTCAAATACTATAAGATGTGTCAAG 3201 GTATTTCTCCAGAATTAATTGCAAAGCTAGTGCTGAAGGATTTTAATCAGCTTCTAAAATTTTCTTCTCAATAAGGCATA 3281 TGTTTTGATTACTTAGGGAAGATTCCTCATTTTTATTTGCCCTTTATGCATTTAATCCACATGATAGGACATTAAAAATT 3361 AATATAAAGAAAAATCGTGCTCATACTGTACATCTGTTTCTGTGCTTGGAACTACTTGTTAATAGTTTTTATCGAAGCTG 3441 TCAGCAATAAGGGACATAAAACTGCTGTATTATACATTGTGGAATTGAATAAACAGCCTAATTTTTTTTTTCTAGTATAG 3521 GGTACTTAAGCATTTCCACTTTTGGAAGAAAAGTGTATTAGTATTTTATATTGCATTTCATTTAAAAGGACAGTTTTTTT 3601 TTTTTTTTTGTAAATCCATTCATTGAAATGGTTTCTAAACTGTATAATGTAATTTGGAGCCTATTTAGTAATAGAATTAA 3681 ATGTCCTATGTAGTGCTACAATTTTTGAATTAGAAAGTGATCAAATGTAAGAAAAAAATTTAAAAATTCAGCCCAGAAAA 3761 CAAAATAGTGTATTAAATTAGTTTAATGTAAAAGGAATTTATAAGATTTTTTTCCTCAATATAGATACCTCACTTGAAAA 3841 GAAAGCACAGCATACTTAAAGTAGTTCTAGTAAACATGTCCTAGAAAACAGTTGCTAAATGTAGGACATCTTTTGAGGAA 3921 TTAGTTTATGAGAAATAAAATTTTACTTGTTTTTACTATCCTGTTAGAAGTATTTGTTTATCCTGATAATTTTAAGCCAA 4001 CATAGTAGTCTTAAATTACTTTTGAATTTCTAATCTGTGAAGGCAGTAAATGAAATATCTGTTCTGCAACTGTTGAAACA 4081 AATAATTGGCTACATTGACCATAATTAAAGTTAAAATTTTGCCAATGATGTACAGTTTTATGGTTAAAGTTGCTGTGGTT 4161 GGTTGCATTACATGACACAGAAAACTGTCCTCTACCTCACGTGAAATAAATATTTTATATGGTTTTACTAAAAATAAGAC 4241 TCATGTATCTGGTCACCTAGTTTACAAATTTTGAATTATATTTATTGAAACATGACATACTGTGCTCTGAGCTTATACCT 4321 CAATTGTATTTTGTGCTGTTTTCCATTTTCATGCCTTGTAAATAACTTGTATAGATTGTGGATCAAATACTAAATAAAAA 4401 CTTTTAATGCCAATTAAATTTGATTCAAGTTAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 6498.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 6498.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 6498.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000458537.3 | 3UTR | UUCAGGAGGGACAACAUCUUCUGCACUUUUUUUUUGCACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000458537.3 | 3UTR | UUUCAGGAGGGACAACAUCUUCUGCACUUUUUUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000458537.3 | 3UTR | GACAACAUCUUCUGCACUUUUUUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000458537.3 | 3UTR | ACAACAUCUUCUGCACUUUUUUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
183 hsa-miR-1470 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT166093 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 8 | ||||||||
MIRT280167 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT306044 | SKIL | SKI like proto-oncogene | 2 | 10 | ||||||||
MIRT348286 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT441956 | MAGEB10 | MAGE family member B10 | 2 | 6 | ||||||||
MIRT471141 | PHF19 | PHD finger protein 19 | 2 | 4 | ||||||||
MIRT489563 | PLD6 | phospholipase D family member 6 | 2 | 2 | ||||||||
MIRT497435 | SEC63 | SEC63 homolog, protein translocation regulator | 2 | 4 | ||||||||
MIRT526684 | CEP72 | centrosomal protein 72 | 2 | 2 | ||||||||
MIRT527821 | TMEM74B | transmembrane protein 74B | 2 | 2 | ||||||||
MIRT529286 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT531944 | AACS | acetoacetyl-CoA synthetase | 2 | 2 | ||||||||
MIRT531988 | SLCO1B3 | solute carrier organic anion transporter family member 1B3 | 2 | 2 | ||||||||
MIRT534822 | RAB30 | RAB30, member RAS oncogene family | 2 | 2 | ||||||||
MIRT540296 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT547507 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT570901 | METTL21A | methyltransferase like 21A | 2 | 2 | ||||||||
MIRT570971 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571176 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT572755 | FAM204A | family with sequence similarity 204 member A | 2 | 2 | ||||||||
MIRT575267 | Timp3 | tissue inhibitor of metalloproteinase 3 | 2 | 2 | ||||||||
MIRT609153 | PNMAL2 | paraneoplastic Ma antigen family member 8B | 2 | 2 | ||||||||
MIRT609478 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT610266 | LRRC47 | leucine rich repeat containing 47 | 2 | 2 | ||||||||
MIRT610289 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 2 | ||||||||
MIRT610351 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT610397 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT611378 | KIF26A | kinesin family member 26A | 2 | 2 | ||||||||
MIRT612512 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT612761 | MYOCD | myocardin | 2 | 2 | ||||||||
MIRT613415 | CDH8 | cadherin 8 | 2 | 2 | ||||||||
MIRT613704 | QPRT | quinolinate phosphoribosyltransferase | 2 | 2 | ||||||||
MIRT613815 | ATP6AP1L | ATPase H+ transporting accessory protein 1 like | 2 | 2 | ||||||||
MIRT614171 | MYO1F | myosin IF | 2 | 2 | ||||||||
MIRT614215 | LENG9 | leukocyte receptor cluster member 9 | 2 | 2 | ||||||||
MIRT614226 | TSKU | tsukushi, small leucine rich proteoglycan | 2 | 2 | ||||||||
MIRT614498 | RHOB | ras homolog family member B | 2 | 2 | ||||||||
MIRT614987 | GIPC1 | GIPC PDZ domain containing family member 1 | 2 | 2 | ||||||||
MIRT615223 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT615495 | SHB | SH2 domain containing adaptor protein B | 2 | 2 | ||||||||
MIRT615507 | CNNM3 | cyclin and CBS domain divalent metal cation transport mediator 3 | 2 | 2 | ||||||||
MIRT615537 | PHF1 | PHD finger protein 1 | 2 | 2 | ||||||||
MIRT615551 | TNFSF15 | TNF superfamily member 15 | 2 | 2 | ||||||||
MIRT615955 | SORD | sorbitol dehydrogenase | 2 | 2 | ||||||||
MIRT616479 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT616668 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT616743 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT616761 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT616914 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT617646 | RAB43 | RAB43, member RAS oncogene family | 2 | 2 | ||||||||
MIRT617824 | EMX2 | empty spiracles homeobox 2 | 2 | 2 | ||||||||
MIRT618518 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT618688 | DVL1 | dishevelled segment polarity protein 1 | 2 | 2 | ||||||||
MIRT619465 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT619561 | GABRG2 | gamma-aminobutyric acid type A receptor gamma2 subunit | 2 | 2 | ||||||||
MIRT620005 | C1orf64 | steroid receptor associated and regulated protein | 2 | 2 | ||||||||
MIRT620211 | VN1R1 | vomeronasal 1 receptor 1 | 2 | 2 | ||||||||
MIRT620447 | SEMA3E | semaphorin 3E | 2 | 2 | ||||||||
MIRT621298 | SLC35B1 | solute carrier family 35 member B1 | 2 | 2 | ||||||||
MIRT621813 | TMEM170B | transmembrane protein 170B | 2 | 2 | ||||||||
MIRT622172 | SMYD1 | SET and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT622203 | SLC5A12 | solute carrier family 5 member 12 | 2 | 2 | ||||||||
MIRT622296 | SH3BP5L | SH3 binding domain protein 5 like | 2 | 2 | ||||||||
MIRT622719 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT622894 | PDCL | phosducin like | 2 | 2 | ||||||||
MIRT623109 | NKD1 | naked cuticle homolog 1 | 2 | 2 | ||||||||
MIRT623231 | MON1B | MON1 homolog B, secretory trafficking associated | 2 | 2 | ||||||||
MIRT623549 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT623558 | JPH3 | junctophilin 3 | 2 | 2 | ||||||||
MIRT623670 | HRK | harakiri, BCL2 interacting protein | 2 | 2 | ||||||||
MIRT623731 | GTDC1 | glycosyltransferase like domain containing 1 | 2 | 4 | ||||||||
MIRT623743 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT624182 | DERL2 | derlin 2 | 2 | 2 | ||||||||
MIRT625759 | GPC5 | glypican 5 | 2 | 2 | ||||||||
MIRT625976 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT626301 | KCNK12 | potassium two pore domain channel subfamily K member 12 | 2 | 2 | ||||||||
MIRT626780 | PI4K2B | phosphatidylinositol 4-kinase type 2 beta | 2 | 2 | ||||||||
MIRT627035 | TMEM109 | transmembrane protein 109 | 2 | 4 | ||||||||
MIRT627110 | PDRG1 | p53 and DNA damage regulated 1 | 2 | 2 | ||||||||
MIRT627406 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT628429 | ARRB1 | arrestin beta 1 | 2 | 2 | ||||||||
MIRT629825 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT630871 | UBXN11 | UBX domain protein 11 | 2 | 2 | ||||||||
MIRT630969 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT635311 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT637117 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT639179 | CEP70 | centrosomal protein 70 | 2 | 2 | ||||||||
MIRT640004 | PHF21B | PHD finger protein 21B | 2 | 2 | ||||||||
MIRT640641 | FBXL18 | F-box and leucine rich repeat protein 18 | 2 | 2 | ||||||||
MIRT640825 | GPR107 | G protein-coupled receptor 107 | 2 | 2 | ||||||||
MIRT641252 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT641435 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT641747 | MACROD2 | MACRO domain containing 2 | 2 | 2 | ||||||||
MIRT641891 | SND1 | staphylococcal nuclease and tudor domain containing 1 | 2 | 2 | ||||||||
MIRT642355 | C19orf40 | Fanconi anemia core complex associated protein 24 | 1 | 1 | ||||||||
MIRT644008 | PPP1R3G | protein phosphatase 1 regulatory subunit 3G | 2 | 2 | ||||||||
MIRT644302 | ZSCAN29 | zinc finger and SCAN domain containing 29 | 2 | 2 | ||||||||
MIRT645707 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT645753 | FAM213A | family with sequence similarity 213 member A | 2 | 2 | ||||||||
MIRT646398 | SLC22A6 | solute carrier family 22 member 6 | 2 | 2 | ||||||||
MIRT646575 | XPNPEP3 | X-prolyl aminopeptidase 3 | 2 | 2 | ||||||||
MIRT647555 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 2 | 2 | ||||||||
MIRT648079 | ZMIZ2 | zinc finger MIZ-type containing 2 | 2 | 2 | ||||||||
MIRT648645 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT649128 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT649557 | FAM20B | FAM20B, glycosaminoglycan xylosylkinase | 2 | 2 | ||||||||
MIRT649645 | SAMHD1 | SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT649782 | MRPS27 | mitochondrial ribosomal protein S27 | 2 | 4 | ||||||||
MIRT649944 | SIT1 | signaling threshold regulating transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT650251 | CD68 | CD68 molecule | 2 | 2 | ||||||||
MIRT650716 | KRT32 | keratin 32 | 2 | 2 | ||||||||
MIRT651048 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT651121 | ZNF48 | zinc finger protein 48 | 2 | 2 | ||||||||
MIRT651223 | ZNF225 | zinc finger protein 225 | 2 | 2 | ||||||||
MIRT651278 | ZDHHC5 | zinc finger DHHC-type containing 5 | 2 | 2 | ||||||||
MIRT651400 | ZBTB16 | zinc finger and BTB domain containing 16 | 2 | 2 | ||||||||
MIRT652199 | TRIM39 | tripartite motif containing 39 | 2 | 2 | ||||||||
MIRT652711 | THBS2 | thrombospondin 2 | 2 | 4 | ||||||||
MIRT652764 | TENM4 | teneurin transmembrane protein 4 | 2 | 2 | ||||||||
MIRT653355 | SMG7 | SMG7, nonsense mediated mRNA decay factor | 2 | 2 | ||||||||
MIRT653865 | SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 2 | 2 | ||||||||
MIRT653962 | SEPN1 | selenoprotein N | 2 | 2 | ||||||||
MIRT654464 | RAP2B | RAP2B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT654484 | RANBP2 | RAN binding protein 2 | 2 | 2 | ||||||||
MIRT654697 | PSMB5 | proteasome subunit beta 5 | 2 | 2 | ||||||||
MIRT654919 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT655444 | PALM2-AKAP2 | PALM2-AKAP2 readthrough | 2 | 2 | ||||||||
MIRT655457 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT655607 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT656025 | MYO5A | myosin VA | 2 | 4 | ||||||||
MIRT656303 | METTL1 | methyltransferase like 1 | 2 | 2 | ||||||||
MIRT656373 | MDFI | MyoD family inhibitor | 2 | 4 | ||||||||
MIRT656400 | MCU | mitochondrial calcium uniporter | 2 | 2 | ||||||||
MIRT656416 | MCTP1 | multiple C2 and transmembrane domain containing 1 | 2 | 2 | ||||||||
MIRT656764 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT656907 | KIAA1958 | KIAA1958 | 2 | 2 | ||||||||
MIRT658937 | DPY19L1 | dpy-19 like C-mannosyltransferase 1 | 2 | 2 | ||||||||
MIRT659222 | CXXC5 | CXXC finger protein 5 | 2 | 2 | ||||||||
MIRT659485 | CLDN1 | claudin 1 | 2 | 2 | ||||||||
MIRT660113 | BTBD3 | BTB domain containing 3 | 2 | 2 | ||||||||
MIRT660306 | BHLHE40 | basic helix-loop-helix family member e40 | 2 | 2 | ||||||||
MIRT660335 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT660789 | AKAP2 | A-kinase anchoring protein 2 | 2 | 2 | ||||||||
MIRT661579 | EPHX2 | epoxide hydrolase 2 | 2 | 2 | ||||||||
MIRT661874 | PDLIM5 | PDZ and LIM domain 5 | 2 | 2 | ||||||||
MIRT662257 | C15orf52 | chromosome 15 open reading frame 52 | 2 | 2 | ||||||||
MIRT662699 | SPIRE2 | spire type actin nucleation factor 2 | 2 | 2 | ||||||||
MIRT663316 | TECPR2 | tectonin beta-propeller repeat containing 2 | 2 | 2 | ||||||||
MIRT665967 | SZRD1 | SUZ RNA binding domain containing 1 | 2 | 2 | ||||||||
MIRT666058 | STK40 | serine/threonine kinase 40 | 2 | 2 | ||||||||
MIRT667284 | NAV1 | neuron navigator 1 | 2 | 2 | ||||||||
MIRT667649 | LGALSL | galectin like | 2 | 2 | ||||||||
MIRT668493 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT669357 | BHLHE22 | basic helix-loop-helix family member e22 | 2 | 2 | ||||||||
MIRT691271 | GET4 | golgi to ER traffic protein 4 | 2 | 2 | ||||||||
MIRT695829 | ABCG8 | ATP binding cassette subfamily G member 8 | 2 | 2 | ||||||||
MIRT698670 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT699230 | SLCO3A1 | solute carrier organic anion transporter family member 3A1 | 2 | 2 | ||||||||
MIRT699894 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT710791 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT710951 | AMZ1 | archaelysin family metallopeptidase 1 | 2 | 2 | ||||||||
MIRT711229 | RETSAT | retinol saturase | 2 | 2 | ||||||||
MIRT711638 | PEBP1 | phosphatidylethanolamine binding protein 1 | 2 | 2 | ||||||||
MIRT711969 | APOA5 | apolipoprotein A5 | 2 | 2 | ||||||||
MIRT712079 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT713716 | PAOX | polyamine oxidase | 2 | 2 | ||||||||
MIRT713876 | FAM212B | family with sequence similarity 212 member B | 2 | 2 | ||||||||
MIRT714481 | TBL2 | transducin beta like 2 | 2 | 2 | ||||||||
MIRT714804 | WDPCP | WD repeat containing planar cell polarity effector | 2 | 2 | ||||||||
MIRT715932 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 2 | ||||||||
MIRT716184 | MTRNR2L1 | MT-RNR2-like 1 | 2 | 2 | ||||||||
MIRT716331 | POU5F1 | POU class 5 homeobox 1 | 2 | 2 | ||||||||
MIRT716943 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | 2 | 2 | ||||||||
MIRT717338 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT718115 | CRTC1 | CREB regulated transcription coactivator 1 | 2 | 2 | ||||||||
MIRT719457 | APBA1 | amyloid beta precursor protein binding family A member 1 | 2 | 2 | ||||||||
MIRT719990 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT721362 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT721490 | LTB4R2 | leukotriene B4 receptor 2 | 2 | 2 | ||||||||
MIRT723011 | FADS1 | fatty acid desaturase 1 | 2 | 2 | ||||||||
MIRT723609 | FKRP | fukutin related protein | 2 | 2 | ||||||||
MIRT724827 | HOXB8 | homeobox B8 | 2 | 2 | ||||||||
MIRT731173 | JUN | Jun proto-oncogene, AP-1 transcription factor subunit | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|